BRIEF-Corbus Pharmaceuticals says Resunab granted fast track status by FDA
August 19, 2015 at 07:45 AM EDT
* Corbus Pharmaceuticals says investigational drug Resunab granted fast track status by FDA for the treatment of systemic sclerosis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.